Patients willingness to accept risk-benefit trade-offs in treating Crohn's disease
Publication
, Journal Article
Johnson, FR; Ozdemir, S; Andrews, EB
Published in: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
August 1, 2006
Duke Scholars
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
ISSN
1053-8569
Publication Date
August 1, 2006
Volume
15
Start / End Page
S138 / S139
Publisher
JOHN WILEY & SONS LTD
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Johnson, F. R., Ozdemir, S., & Andrews, E. B. (2006). Patients willingness to accept risk-benefit trade-offs in treating Crohn's disease. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 15, S138–S139.
Johnson, F Reed, Semra Ozdemir, and Elizabeth B. Andrews. “Patients willingness to accept risk-benefit trade-offs in treating Crohn's disease.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 15 (August 1, 2006): S138–39.
Johnson FR, Ozdemir S, Andrews EB. Patients willingness to accept risk-benefit trade-offs in treating Crohn's disease. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2006 Aug 1;15:S138–9.
Johnson, F. Reed, et al. “Patients willingness to accept risk-benefit trade-offs in treating Crohn's disease.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 15, JOHN WILEY & SONS LTD, Aug. 2006, pp. S138–39.
Johnson FR, Ozdemir S, Andrews EB. Patients willingness to accept risk-benefit trade-offs in treating Crohn's disease. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. JOHN WILEY & SONS LTD; 2006 Aug 1;15:S138–S139.
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
ISSN
1053-8569
Publication Date
August 1, 2006
Volume
15
Start / End Page
S138 / S139
Publisher
JOHN WILEY & SONS LTD
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences